JPMorgan Chase & Co’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.72M | Buy |
247,424
+112,116
| +83% | +$2.59M | ﹤0.01% | 2596 |
|
|
2025
Q1 | $3.65M | Sell |
135,308
-56,295
| -29% | -$1.52M | ﹤0.01% | 2869 |
|
|
2024
Q4 | $10.3M | Buy |
191,603
+173,211
| +942% | +$9.27M | ﹤0.01% | 2218 |
|
|
2024
Q3 | $836K | Sell |
18,392
-821
| -4% | -$37.3K | ﹤0.01% | 3744 |
|
|
2024
Q2 | $805K | Sell |
19,213
-130
| -0.7% | -$5.45K | ﹤0.01% | 3619 |
|
|
2024
Q1 | $728K | Buy |
19,343
+1,607
| +9% | +$60.5K | ﹤0.01% | 3745 |
|
|
2023
Q4 | $190K | Sell |
17,736
-130,873
| -88% | -$1.4M | ﹤0.01% | 4465 |
|
|
2023
Q3 | $1.5M | Sell |
148,609
-4,827
| -3% | -$48.7K | ﹤0.01% | 3182 |
|
|
2023
Q2 | $1.82M | Buy |
153,436
+23,779
| +18% | +$282K | ﹤0.01% | 3088 |
|
|
2023
Q1 | $1.57M | Buy |
129,657
+25,874
| +25% | +$313K | ﹤0.01% | 3180 |
|
|
2022
Q4 | $1.37M | Sell |
103,783
-1,270
| -1% | -$16.7K | ﹤0.01% | 3202 |
|
|
2022
Q3 | $1.42M | Buy |
105,053
+1,575
| +2% | +$21.3K | ﹤0.01% | 3141 |
|
|
2022
Q2 | $1.26M | Buy |
103,478
+85,552
| +477% | +$1.05M | ﹤0.01% | 3315 |
|
|
2022
Q1 | $256K | Buy |
17,926
+4,638
| +35% | +$66.2K | ﹤0.01% | 4324 |
|
|
2021
Q4 | $262K | Buy |
13,288
+6,814
| +105% | +$134K | ﹤0.01% | 4396 |
|
|
2021
Q3 | $140K | Buy |
6,474
+5,828
| +902% | +$126K | ﹤0.01% | 4562 |
|
|
2021
Q2 | $16K | Buy |
+646
| New | +$16K | ﹤0.01% | 5152 |
|